| | | |
P value
|
---|
RiskaSNP/haplotype
|
AntiCCP+ (n = 612)
|
AntiCCP-(n = 111)
|
Control
|
CCP + vs. CCP-b
|
CCP + vs. Controlc
|
CCP- vs. Controld
|
---|
rs11889341
|
35.2
|
34.5
|
29.7
|
0.84
|
0.001
|
0.14
|
rs7574865
|
38.8
|
38.6
|
32.9
|
0.96
|
0.001
|
0.11
|
rs8179673
|
38.9
|
40.0
|
34.0
|
0.77
|
0.005
|
0.08
|
rs10181656
|
38.9
|
40.0
|
34.2
|
0.76
|
0.007
|
0.09
|
Haplotype, TTCG
|
34.2
|
32.4
|
28.5
|
0.62
|
0.0009
|
0.23
|
- aOnly 723 cases with anti-CCP data were compared with a total of 1008 controls.
- bAll alleles and haplotype had statistically significant risk for anti-CCP positive RA compared with control [ORs (95% CI) 1.29 (1.11–1.50), 1.28 (1.10–1.51), 1.24 (1.07–1.43), 1.23 (1.06–1.42), and 1.29 (1.11–1.51) in order]
- cThe distribution of risk alleles and haplotype between antiCCP positive and negative groups were not significantly different.
- dP values of the risk alleles and haplotype in the anti-CCP negative group were not statistically significant level compared with control group.